(Q31016306)

19 October 2017

Genetic factors associated with patient-specific warfarin dose in ethnic Indonesians (English)

1 reference

19 October 2017

0 references

1 reference

1 reference

Ivet M Suriapranata

1

1 reference

19 October 2017

Wen Ye Tjong

2

1 reference

19 October 2017

Tingliang Wang

3

1 reference

19 October 2017

Andi Utama

4

1 reference

19 October 2017

Sunu B Raharjo

5

1 reference

19 October 2017

Yoga Yuniadi

6

1 reference

19 October 2017

Susan Sw Tai

7

1 reference

19 October 2017

6 June 2011

1 reference

19 October 2017

1 reference

19 October 2017

12

1 reference

19 October 2017

80

1 reference

A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans

19 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133537

Warfarin sensitivity genotyping: a review of the literature and summary of patient experience

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133537

Influence of CYP2C9 Genotype on warfarin dose among African American and European Americans

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133537

CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133537

A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133537

A haplotype of the CYP4F2 gene associated with myocardial infarction in Japanese men.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133537

VKORC1 polymorphisms, haplotypes and haplotype groups on warfarin dose among African-Americans and European-Americans

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133537

Genetic factors contribute to patient-specific warfarin dose for Han Chinese

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133537

A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133537

CYP4F2 genetic variant alters required warfarin dose

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133537

Association of a functional cytochrome P450 4F2 haplotype with urinary 20-HETE and hypertension

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133537

Influence of APOE genotypes and VKORC1 haplotypes on warfarin dose requirements in Asian patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133537

A "silent" polymorphism in the MDR1 gene changes substrate specificity

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133537

Association of warfarin dose with genes involved in its action and metabolism

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133537

Allele and genotype frequencies of CYP2C9 in a Korean population

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133537

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133537

A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133537

Common VKORC1 and GGCX polymorphisms associated with warfarin dose

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133537

Pharmacogenetics of oral anticoagulants

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133537

Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133537

Molecular basis of ethnic differences in drug disposition and response

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133537

Human P450 metabolism of warfarin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133537

Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133537

Point: use of pharmacogenetics in guiding treatment with warfarin

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-12-80

Association of Vitamin K epoxide reductase complex 1 (VKORC1) variants with warfarin dose in a Hong Kong Chinese patient population

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-12-80

Discovery of new potentially defective alleles of human CYP2C9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-12-80

Upstream and coding region CYP2C9 polymorphisms: correlation with warfarin dose and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-12-80

Identification of a novel variant CYP2C9 allele in Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-12-80

Genotypes of vitamin K epoxide reductase, gamma-glutamyl carboxylase, and cytochrome P450 2C9 as determinants of daily warfarin dose in Japanese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-12-80

Genetic determinants of warfarin dosing in the Han-Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-12-80

Warfarin and cytochrome P450 2C9 genotype: possible ethnic variation in warfarin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-12-80

Interethnic variability of warfarin maintenance requirement is explained by VKORC1 genotype in an Asian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-12-80

Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-12-80

CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-12-80

Effects of CYP4F2 genetic polymorphisms and haplotypes on clinical outcomes in patients initiated on warfarin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-12-80

A farewell to Bonferroni: the problems of low statistical power and publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-12-80

CYP2C9 polymorphism: prevalence in healthy and warfarin-treated Malay and Chinese in Malaysia.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133537

Apolipoprotein E genotype and warfarin dosing among Caucasians and African Americans

25 November 2018

1 reference

12 December 2020

Warfarin Response and Vitamin K Epoxide Reductase Complex 1 in African Americans and Caucasians

1 reference

12 December 2020

Estimation of warfarin maintenance dose based on VKORC1 (-1639 G>A) and CYP2C9 genotypes

1 reference

12 December 2020

The association of CYP2C9 gene polymorphisms with colorectal carcinoma in Han Chinese

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2350-12-80

1 reference

19 October 2017

1 reference

19 October 2017

PubMed publication ID

21639946

1 reference